Verition Fund Management
CAI

Verition Fund Management’s Caris Life Sciences CAI Stock Holding History

Verition Fund Management’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,000
Closed -$358K – 2636
2026
Q1 		$358K Buy
+20,000
New +$437K ﹤0.01% 1710
2025
Q4 		– Sell
-30,910
Closed -$935K – 4054
2025
Q3 		$935K Buy
+30,910
New +$986K ﹤0.01% 2585

Other funds holding CAI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JHWEPV
J. H. Whitney Equity Partners VI New Canaan, Connecticut $201M AUM
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SSP
Sixth Street Partners Dallas, Texas $579M AUM 2.46% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Verition Fund Management's CAI Position: Q2 2026 in Review

Verition Fund Management sold out of Caris Life Sciences (CAI) in Q2 2026, closing a stake of 20,000 shares — an estimated $358K sold.

Verition Fund Management first reported a position in CAI in Q3 2025 and held it in 2 quarters. The position peaked at $935K in Q3 2025. 246 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Verition Fund Management reported no remaining Caris Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Verition Fund Management sold 20,000 Caris Life Sciences shares in Q2 2026, an estimated $358K.
  • Verition Fund Management first reported a position in Caris Life Sciences in Q3 2025 and held it in 2 quarters.
  • Verition Fund Management's Caris Life Sciences position peaked at $935K in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.